Eton Pharmaceuticals Inc

NASDAQ:ETON   12:00:22 PM EDT
5.50
-0.06 (-1.08%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)135.30M
Current PEN/A
Forward PE 32.35
2yr Forward PE 20.37
See more stats
Estimates Current Quarter
Revenue$4.77 Million
Adjusted EPS-$0.11
See more estimates
10-Day MA$5.32
50-Day MA$4.99
200-Day MA$6.85
See more pivots

Eton Pharmaceuticals Inc Stock, NASDAQ:ETON

21925 West Field Parkway, Suite 235, Deer Park, Illinois 60010-7208
United States of America
Phone: +1.847.787.7361
Number of Employees: 16

Description

Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.